George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 301.00
Ask: 309.00
Change: 12.00 (4.11%)
Spread: 8.00 (2.658%)
Open: 309.00
High: 309.00
Low: 301.00
Prev. Close: 292.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Primacy Corporation

27 Feb 2017 07:00

RNS Number : 8550X
Microgen PLC
27 February 2017
 

microgen

www.microgen.com 27 February 2017

 

 

 

ACQUISITION OF PRIMACY CORPORATION

 

Microgen plc ('Microgen') is pleased to announce the acquisition of Primacy Corporation ('Primacy') from the Kelly Family Trust for total cash consideration of CAD5.6 million (Canadian Dollars) (£3.4 million). Primacy is a Toronto-based provider of software to the Trust & Fund Administration market and will be integrated into the Microgen Financial Systems business.

 

Primacy is the fifth acquisition by Microgen since December 2014 and continues the Group's strategy of consolidation in the Trust & Fund Administration market, a global niche within the broader Wealth Management sector. These acquisitions provide Microgen with an increased client and recurring revenue base and complement the organic growth in Microgen 5Series revenues resulting in the Microgen Financial Systems business becoming increasingly focussed on Trust & Fund Administration.

 

Primacy's revenue in the year ending 31 October 2016 was CAD2.0 million (£1.2 million) with profit before tax of CAD0.9 million (£0.6 million). The gross assets at 31 October 2016 were CAD1.2 million (£0.7 million) and it is anticipated that at completion there will be cash and net funds of approximately CAD0.2 million (£0.1 million). The acquisition of Primacy is anticipated to be earnings enhancing in the current financial year and is funded through Microgen's existing cash resources.

 

As previously announced, Microgen expects to announce its preliminary results for the year ending 31 December 2016 on 8 March 2017.

 

Contacts

Philip Wood, Chief Financial Officer 020-7496-8100

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBIGDDBUDBGRS
Date   Source Headline
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSNotice of 2024 Annual General Meeting
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:46 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:01 amRNSAptitude to Accelerate Autonomous Finance
21st Mar 20247:01 amRNSShare buyback programme
21st Mar 20247:00 amRNSAudited Results for Year Ended 31 December 2023
21st Feb 20247:00 amRNSChange of Broker Arrangements
9th Feb 20247:00 amRNSHolding(s) in Company
31st Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
4th Jan 20247:00 amRNSFynapse Win
30th Nov 20237:00 amRNSAppointment of Chief Executive Officer
12th Oct 20237:00 amRNSHolding(s) in Company
2nd Oct 20232:17 pmRNSGrant of awards
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.